Insider Trading activities of Cancer Genetics, Inc (CGIX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cancer Genetics, Inc (CGIX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cancer Genetics, Inc since year 2005. Table 2 shows the detailed insider transactions of Cancer Genetics, Inc since 2005. The reporting company's ticker symbol is CGIX. The reporting company's CIK number is 1349929.
The total value of stock buying since 2005 is $4,174,870.
The total value of stock sales since 2005 is $1,750,070.
The total value of stock option exercises since 2005 is $179,494.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Cancer Genetics, Inc (CGIX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-01 2,578,915 $587,150 0 $0 0 $0
2017-12 162,200 $303,339 0 $0 0 $0
2017-08 86,185 $280,704 0 $0 0 $0
2017-06 100,000 $374,900 0 $0 0 $0
2017-05 22,747 $86,396 937 $3,762 937 $2,342
2016-12 2,500 $3,750 0 $0 0 $0
2016-11 136,100 $199,109 3,333 $5,192 0 $0
2016-08 192,500 $421,484 0 $0 0 $0
2016-05 317,820 $0 0 $0 0 $0
2016-03 152,540 $391,496 0 $0 0 $0
2015-11 105,000 $0 0 $0 0 $0
2015-08 5,000 $48,060 0 $0 0 $0
2015-06 0 $0 83,333 $1,002,116 0 $0
2015-05 10,000 $107,649 0 $0 0 $0
2015-03 51,000 $374,802 0 $0 0 $0
2014-12 82,269 $470,061 0 $0 0 $0
2014-06 0 $0 0 $0 44,288 $177,152
2014-05 51,000 $525,970 0 $0 0 $0
2013-11 0 $0 50,000 $739,000 0 $0
2013-04 738,430 $0 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Cancer Genetics, Inc insiders (CGIX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-01-31 Miles Michael Glenn (Chief Financial Officer) Buy 150,000 .23 34,500
2019-01-31 Cannon Edmund Buy 43,479 .23 10,000
2019-01-31 Roberts John A (Chief Executive Officer) Buy 185,436 .23 42,650
2019-01-31 Pappajohn John Buy 1,000,000 .23 230,000
2019-01-14 Harris Geoffrey E. Buy 100,000 .23 22,500
2019-01-14 Roberts John A (Chief Executive Officer) Buy 100,000 .23 22,500
2019-01-14 Pappajohn John Buy 1,000,000 .23 225,000
2017-12-15 Roberts John A (Chief Operating Officer) Buy 12,200 2.00 24,339
2017-12-08 Pappajohn John Buy 150,000 1.86 279,000
2017-08-17 Pappajohn John Buy 86,185 3.26 280,704
2017-06-12 Pappajohn John Buy 100,000 3.75 374,900
2017-05-25 Gitelman Igor (Chief Accounting Officer) Buy 937 3.95 3,701
2017-05-23 Gitelman Igor (Chief Accounting Officer) Sale 937 4.02 3,762
2017-05-23 Gitelman Igor (Chief Accounting Officer) Option Ex 937 2.50 2,342
2017-05-16 Harris Geoffrey E. Buy 2,500 3.75 9,375
2017-05-16 Pappajohn John Buy 19,310 3.80 73,320
2016-12-14 Harris Geoffrey E. Buy 2,500 1.50 3,750
2016-11-28 Pappajohn John Buy 100,000 1.45 145,300
2016-11-16 Sitar Edward J (Chief Financial Officer) Sale 3,333 1.56 5,192
2016-11-14 Harris Geoffrey E. Buy 5,000 1.55 7,750
2016-11-14 Pappajohn John Buy 31,100 1.48 46,059
2016-08-16 Pappajohn John Buy 45,000 2.29 103,185
2016-08-15 Pappajohn John Buy 79,722 2.20 175,627
2016-08-12 Pappajohn John Buy 67,778 2.10 142,672
2016-05-25 Pappajohn John Buy 317,820 .00 0
2016-03-17 Sharma Panna (Chief Executive Officer) Buy 500 2.58 1,290
2016-03-17 Pappajohn John Buy 50,000 2.64 132,050
2016-03-16 Welsh Michael J. Buy 40 2.42 96
2016-03-16 Sharma Panna (Chief Executive Officer) Buy 1,000 2.60 2,600
2016-03-16 Pappajohn John Buy 10,579 2.62 27,738
2016-03-15 Sharma Panna (Chief Executive Officer) Buy 1,000 2.56 2,560
2016-03-15 Pappajohn John Buy 89,421 2.52 225,162
2015-11-12 Sitar Edward J (Chief Financial Officer) Buy 5,000 .00 0
2015-11-12 Pappajohn John Buy 100,000 .00 0
2015-08-27 Pappajohn John Buy 2,500 10.25 25,625
2015-08-26 Pappajohn John Buy 2,500 8.97 22,435
2015-06-25 Chaganti Raju S.k. Sale 5,296 12.00 63,552
2015-06-12 Chaganti Raju S.k. Sale 7,000 12.01 84,049
2015-06-11 Chaganti Raju S.k. Sale 15,900 12.04 191,515
2015-06-10 Chaganti Raju S.k. Sale 22,817 12.03 274,397
2015-06-09 Chaganti Raju S.k. Sale 7,737 12.01 92,944
2015-06-08 Chaganti Raju S.k. Sale 24,583 12.03 295,659
2015-05-14 Harris Geoffrey E. Buy 5,000 10.79 53,949
2015-05-14 Pappajohn John Buy 5,000 10.74 53,700
2015-03-17 Pappajohn John Buy 15,000 7.15 107,235
2015-03-16 Sitar Edward J (Chief Financial Officer) Buy 1,000 6.99 6,992
2015-03-16 Pappajohn John Buy 35,000 7.45 260,575
2014-12-16 Pappajohn John Buy 5,589 6.20 34,651
2014-12-15 Pappajohn John Buy 3,634 6.14 22,312
2014-12-12 Sitar Edward J (Chief Financial Officer) Buy 500 6.26 3,130
2014-12-11 Pappajohn John Buy 27,087 6.03 163,334
2014-12-10 Pappajohn John Buy 5,773 5.96 34,407
2014-12-09 Pappajohn John Buy 15,986 5.70 91,120
2014-12-08 Pappajohn John Buy 23,700 5.11 121,107
2014-06-10 Pappajohn John Option Ex 44,288 4.00 177,152
2014-05-21 Sitar Edward J (Chief Financial Officer) Buy 1,000 10.67 10,670
2014-05-21 Pappajohn John Buy 5,000 10.66 53,300
2014-05-20 Pappajohn John Buy 30,000 10.35 310,500
2014-05-19 Pappajohn John Buy 15,000 10.10 151,500
2013-11-18 Pecora Andrew L Sale 50,000 14.78 739,000
2013-04-10 Chaganti Raju S.k. (Director) Buy 13,430 .00 0
2013-04-10 Pecora Andrew L (Director) Buy 50,000 .00 0
2013-04-10 Pappajohn John (Director) Buy 675,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of CGIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cancer Genetics, Inc (symbol CGIX, CIK number 1349929) see the Securities and Exchange Commission (SEC) website.